Resveratrol inhibits nonalcoholic fatty liver disease in rats

Resveratrol inhibits nonalcoholic fatty liver disease in rats

<p>Abstract</p> <p>Background</p> <p>The prevalence of nonalcoholic fatty liver disease (NAFLD) is high. NAFLD is linked to obesity, diabetes mellitus, and hypertriglyceridemia. Approximately 20% of patients with NAFLD will eventually develop cirrhosis. Our purpose was...

Full description

Bibliographic Details
Main Authors: Irastorza Belen, Cosme Angel, Sarasqueta Cristina, Aldazabal Pablo, García-Urkia Nerea, Larzabal Mikel, Beraza Marta, Hijona Elizabeth, Bujanda Luis, González Alberto, Arenas Juan I
Format: Article
Language:English
Published: BMC 2008-09-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/8/40

Internet

http://www.biomedcentral.com/1471-230X/8/40

Similar Items